vs
罗宾汉（HOOD）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
罗宾汉的季度营收约是Revvity的1.2倍（$927.0M vs $772.1M），罗宾汉净利率更高（36.2% vs 12.7%，领先23.5%），Revvity同比增速更快（5.9% vs -27.7%），过去两年罗宾汉的营收复合增速更高（16.6% vs 9.0%）
罗宾汉市场（Robinhood Markets, Inc.）是总部位于美国加利福尼亚州门洛帕克的金融服务企业，旗下电子交易平台支持股票、ETF、期权、期货、加密货币等品类交易，还提供加密货币钱包、财富管理、信用卡等金融服务，部分银行服务与FDIC投保银行合作推出，同时运营新闻网站Sherwood.News。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
HOOD vs RVTY — 直观对比
营收规模更大
HOOD
是对方的1.2倍
$772.1M
营收增速更快
RVTY
高出33.6%
-27.7%
净利率更高
HOOD
高出23.5%
12.7%
两年增速更快
HOOD
近两年复合增速
9.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $927.0M | $772.1M |
| 净利润 | $336.0M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | — | 14.5% |
| 净利率 | 36.2% | 12.7% |
| 营收同比 | -27.7% | 5.9% |
| 净利润同比 | -2.9% | 3.9% |
| 每股收益（稀释后） | $336.00 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HOODRVTY
| Q1 26 | $927.0M | — | ||
| Q4 25 | $1.3B | $772.1M | ||
| Q3 25 | $1.3B | $698.9M | ||
| Q2 25 | $989.0M | $720.3M | ||
| Q1 25 | $927.0M | $664.8M | ||
| Q4 24 | $1.0B | $729.4M | ||
| Q3 24 | $637.0M | $684.0M | ||
| Q2 24 | $682.0M | $691.7M |
净利润HOODRVTY
| Q1 26 | $336.0M | — | ||
| Q4 25 | $605.0M | $98.4M | ||
| Q3 25 | $556.0M | $46.7M | ||
| Q2 25 | $386.0M | $53.9M | ||
| Q1 25 | $336.0M | $42.2M | ||
| Q4 24 | $916.0M | $94.6M | ||
| Q3 24 | $150.0M | $94.4M | ||
| Q2 24 | $188.0M | $55.4M |
毛利率HOODRVTY
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% |
营业利润率HOODRVTY
| Q1 26 | — | — | ||
| Q4 25 | 51.5% | 14.5% | ||
| Q3 25 | 49.8% | 11.7% | ||
| Q2 25 | 44.7% | 12.6% | ||
| Q1 25 | 40.0% | 10.9% | ||
| Q4 24 | 55.0% | 16.3% | ||
| Q3 24 | 24.0% | 14.3% | ||
| Q2 24 | 28.0% | 12.4% |
净利率HOODRVTY
| Q1 26 | 36.2% | — | ||
| Q4 25 | 47.2% | 12.7% | ||
| Q3 25 | 43.6% | 6.7% | ||
| Q2 25 | 39.0% | 7.5% | ||
| Q1 25 | 36.2% | 6.4% | ||
| Q4 24 | 90.3% | 13.0% | ||
| Q3 24 | 23.5% | 13.8% | ||
| Q2 24 | 27.6% | 8.0% |
每股收益（稀释后）HOODRVTY
| Q1 26 | $336.00 | — | ||
| Q4 25 | $0.65 | $0.86 | ||
| Q3 25 | $0.61 | $0.40 | ||
| Q2 25 | $0.42 | $0.46 | ||
| Q1 25 | $0.37 | $0.35 | ||
| Q4 24 | $1.00 | $0.77 | ||
| Q3 24 | $0.17 | $0.77 | ||
| Q2 24 | $0.21 | $0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3B | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $9.2B | $7.3B |
| 总资产 | $38.1B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HOODRVTY
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $919.9M | ||
| Q3 25 | $4.3B | $931.4M | ||
| Q2 25 | $4.2B | $991.8M | ||
| Q1 25 | $4.4B | $1.1B | ||
| Q4 24 | $4.3B | $1.2B | ||
| Q3 24 | $4.6B | $1.2B | ||
| Q2 24 | $4.5B | $2.0B |
股东权益HOODRVTY
| Q1 26 | $9.2B | — | ||
| Q4 25 | $9.2B | $7.3B | ||
| Q3 25 | $8.6B | $7.4B | ||
| Q2 25 | $8.1B | $7.6B | ||
| Q1 25 | $8.0B | $7.6B | ||
| Q4 24 | $8.0B | $7.7B | ||
| Q3 24 | $7.2B | $7.9B | ||
| Q2 24 | $7.1B | $7.9B |
总资产HOODRVTY
| Q1 26 | $38.1B | — | ||
| Q4 25 | $38.1B | $12.2B | ||
| Q3 25 | $41.5B | $12.1B | ||
| Q2 25 | $35.3B | $12.4B | ||
| Q1 25 | $27.5B | $12.4B | ||
| Q4 24 | $26.2B | $12.4B | ||
| Q3 24 | $43.2B | $12.8B | ||
| Q2 24 | $41.3B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $642.0M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | 1.91× | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流HOODRVTY
| Q1 26 | $642.0M | — | ||
| Q4 25 | $-937.0M | $182.0M | ||
| Q3 25 | $-1.6B | $138.5M | ||
| Q2 25 | $3.5B | $134.3M | ||
| Q1 25 | $642.0M | $128.2M | ||
| Q4 24 | $-1.4B | $174.2M | ||
| Q3 24 | $1.8B | $147.9M | ||
| Q2 24 | $54.0M | $158.6M |
自由现金流HOODRVTY
| Q1 26 | — | — | ||
| Q4 25 | — | $161.8M | ||
| Q3 25 | — | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M |
自由现金流率HOODRVTY
| Q1 26 | — | — | ||
| Q4 25 | — | 21.0% | ||
| Q3 25 | — | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% |
资本支出强度HOODRVTY
| Q1 26 | — | — | ||
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% |
现金转化率HOODRVTY
| Q1 26 | 1.91× | — | ||
| Q4 25 | -1.55× | 1.85× | ||
| Q3 25 | -2.83× | 2.97× | ||
| Q2 25 | 9.09× | 2.49× | ||
| Q1 25 | 1.91× | 3.03× | ||
| Q4 24 | -1.53× | 1.84× | ||
| Q3 24 | 12.08× | 1.57× | ||
| Q2 24 | 0.29× | 2.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HOOD
| Transaction-based revenues | $583.0M | 63% |
| Other | $290.0M | 31% |
| Other revenues | $54.0M | 6% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
